These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33535640)

  • 41. Biomarkers from subcutaneous engineered tissues predict acute rejection of organ allografts.
    Urie RR; Morris A; Farris D; Hughes E; Xiao C; Chen J; Lombard E; Feng J; Li JZ; Goldstein DR; Shea LD
    Sci Adv; 2024 May; 10(20):eadk6178. PubMed ID: 38748794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
    Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exosomes from dendritic cells with Mettl3 gene knockdown prevent immune rejection in a mouse cardiac allograft model.
    Wu H; Xu Z; Wang Z; Ren Z; Li L; Ruan Y
    Immunogenetics; 2020 Oct; 72(8):423-430. PubMed ID: 33009922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients.
    Battes LC; Caliskan K; Rizopoulos D; Constantinescu AA; Robertus JL; Akkerhuis M; Manintveld OC; Boersma E; Kardys I
    Transplantation; 2015 Mar; 99(3):580-5. PubMed ID: 25136844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection.
    Adam N; Coutance G; Viailly PJ; Drieux F; Ruminy P; Sater AA; Toquet C; Rouvier P; François A; Chenard MP; Epailly E; Guillemain R; Pattier S; Gay A; Varnous S; Taupin JL; Rabant M; Loupy A; Bruneval P; Duong Van Huyen JP
    J Heart Lung Transplant; 2020 Feb; 39(2):115-124. PubMed ID: 31822443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma CD5L and non-invasive diagnosis of acute heart rejection.
    Tarazón E; Corbacho-Alonso N; Barderas MG; Gil-Cayuela C; García-Manzanares M; Feijóo-Bandín S; Lago F; González-Juanatey JR; Martínez-Dolz L; Portolés M; Roselló-Lletí E
    J Heart Lung Transplant; 2020 Mar; 39(3):257-266. PubMed ID: 31883820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study.
    Starling RC; Stehlik J; Baran DA; Armstrong B; Stone JR; Ikle D; Morrison Y; Bridges ND; Putheti P; Strom TB; Bhasin M; Guleria I; Chandraker A; Sayegh M; Daly KP; Briscoe DM; Heeger PS;
    Am J Transplant; 2016 Jan; 16(1):121-36. PubMed ID: 26260101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Failing to Make the Grade: Conventional Cardiac Allograft Rejection Grading Criteria Are Inadequate for Predicting Rejection Severity.
    Arabyarmohammadi S; Yuan C; Viswanathan VS; Lal P; Feldman MD; Fu P; Margulies KB; Madabhushi A; Peyster EG
    Circ Heart Fail; 2024 Feb; 17(2):e010950. PubMed ID: 38348670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
    Husain AN; Mirza KM; Fedson SE
    J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies.
    Cai Q; Moore SA; Hendricks AR; Torrealba JR
    Transplant Proc; 2020 May; 52(4):1192-1197. PubMed ID: 32197864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The exosome as a novel predictive/diagnostic biomarker of rejection in the field of transplantation.
    Mirzakhani M; Mohammadnia-Afrouzi M; Shahbazi M; Mirhosseini SA; Hosseini HM; Amani J
    Clin Immunol; 2019 Jun; 203():134-141. PubMed ID: 31077803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Key driver genes as potential therapeutic targets in renal allograft rejection.
    Yi Z; Keung KL; Li L; Hu M; Lu B; Nicholson L; Jimenez-Vera E; Menon MC; Wei C; Alexander S; Murphy B; O'Connell PJ; Zhang W
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32634125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small Extracellular Vesicles in Transplant Rejection.
    Gołębiewska JE; Wardowska A; Pietrowska M; Wojakowska A; Dębska-Ślizień A
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tanshinol suppresses cardiac allograft rejection in a murine model.
    Lu C; Zeng YQ; Liu H; Xie Q; Xu S; Tu K; Dou C; Dai Z
    J Heart Lung Transplant; 2017 Feb; 36(2):227-236. PubMed ID: 27574736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection.
    Khachatoorian Y; Khachadourian V; Chang E; Sernas ER; Reed EF; Deng M; Piening BD; Pereira AC; Keating B; Cadeiras M
    Transplant Rev (Orlando); 2021 Jan; 35(1):100590. PubMed ID: 33401139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reliability of tissue Doppler wall motion monitoring after heart transplantation for replacement of invasive routine screenings by optimally timed cardiac biopsies and catheterizations.
    Dandel M; Hummel M; Müller J; Wellnhofer E; Meyer R; Solowjowa N; Ewert R; Hetzer R
    Circulation; 2001 Sep; 104(12 Suppl 1):I184-91. PubMed ID: 11568053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid Biopsy.
    Verhoeven JGHP; Hesselink DA; Peeters AMA; de Jonge E; von der Thüsen JH; van Schaik RHN; Matic M; Baan CC; Manintveld OC; Boer K
    Transpl Int; 2022; 35():10122. PubMed ID: 35387397
    [No Abstract]   [Full Text] [Related]  

  • 59. Exosomes in transplantation: Role in allograft rejection, diagnostic biomarker, and therapeutic potential.
    Saravanan PB; Kalivarathan J; Khan F; Shah R; Levy MF; Kanak MA
    Life Sci; 2023 Jul; 324():121722. PubMed ID: 37100379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of stress proteins and lymphocyte reactivity in heterotopic cardiac allografts undergoing cellular rejection.
    Qian J; Moliterno R; Donovan-Peluso MA; Liu K; Suzow J; Valdivia L; Pan F; Duquesnoy RJ
    Transpl Immunol; 1995 Jun; 3(2):114-23. PubMed ID: 7582902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.